You are here: Industry Insights > Sanofi

News List

Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi biospace
February 02, 2018
Only a week after launch, Partner Therapeutics, or PTx, acquired the global rights to Leukine (sargramaostin) from Paris-based Sanofi.
3 FDA Decisions to Look Out for in February biospace
February 02, 2018
The year is getting off to a good start for mergers and acquisitions, with Sanofi buying Bioverativ for $11.6 billion and Ablynx for $4.8 billion, Celgene acquiring Juno Therapeutics for $9 billion, and Seattle Genetics buying Cascadian Therapeutics for $
Philippines' Department of Health demands full refund of $70m Dengvaxia programme from Sanofi pharmafile
January 31, 2018
In the latest update of the Sanofi Philippines dengue vaccine scandal, the U.S. Department of Health demanded that French pharmaceutical companies pay a full refund of the three billion Philippine pesos paid by the Philippine government to immunize its ci
Ablynx enters €3.9bn acquisition deal with Sanofi pharmaceutical-technology
January 31, 2018
Belgium-based Ablynx has signed a definitive agreement, under which all of its outstanding shares will be purchased by French firm Sanofi at €45 per share, amounting to a total of about €3.9bn.
Sanofi agreed to buy Ablynx for $4.8 B biospectrumasia
January 30, 2018
The acquisition of Ablynx continues Sanofi's commitment to breakthrough innovation, focused on technologies addressing multiple disease targets with single multi-specific molecules
No Deal for Novo as Sanofi Swoops in With $4.85B Win for Ablynx biospace
January 30, 2018
Only a week after Sanofi ponied up $11.6 billion to buy Waltham, Massachusetts-based Bioverativ, the French drugmaker is buying Ghent, Belgium-based Ablynx for $4.8 billion.
Sanofi confirmed the deal to buy Bioverativ for $11.6 B biospectrumasia
January 24, 2018
The French healthcare company intends to boost its earnings and strengthen its presence in the field of treatments for rare diseases.
Sanofi adopts TriNetX platform to speed clinical trials biospectrumasia
January 24, 2018
Cambridge, MA based TriNetX operates a cloud-accessible federated health research platform.
Forensic Exam Shows Pattern in 4 Deaths of Sanofi Dengue Vaccine Recipients biospace
January 11, 2018
Forensic examination conducted on 4 children who received a controversial dengue vaccine indicated a "pattern" that led to their deaths, the Public Attorney's Office said Wednesday.
Sanofi, Regeneron beef up investment in immunotherapies pharmatimes
January 10, 2018
Sanofi and Regeneron are boosting their investment in development programmes for the PD-1 antibody cemiplimab in oncology and dupilumab in Type 2 (tissue specific) allergic diseases.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page